Bispecific antibodies and diabodies for cancer immunotherapy.
Ursula
U
Elsässer-Beile
Patrick
P
Bühler
D000818:Animals; D018033:Antibodies, Bispecific / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology*; D002986:Clinical Trials as Topic; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D006801:Humans; D007167:Immunotherapy; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D057127:Single-Chain Antibodies / Q000235:genetics / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology*
D018033:Antibodies, Bispecific; D015703:Antigens, CD; D000951:Antigens, Neoplasm; D011948:Receptors, Antigen, T-Cell; D057127:Single-Chain Antibodies